Insider Buy/Sell Details for the Biotechnology Industry — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1179)
AN2 Therapeutics, Inc. (ANTX)
Williams Sarah Joanne — Principal Accounting Officer
Shares
327
Price
$1.06
Total Value
$346.62
Shares Held After
66,848
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
421
Price
$507.09
Total Value
$213.49K
Shares Held After
130
% of Holdings
76.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
132
Price
$506.16
Total Value
$66.81K
Shares Held After
551
% of Holdings
19.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
908
Price
$505.06
Total Value
$458.59K
Shares Held After
683
% of Holdings
57.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
730
Price
$503.99
Total Value
$367.91K
Shares Held After
1,591
% of Holdings
31.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
210
Price
$503.03
Total Value
$105.64K
Shares Held After
2,321
% of Holdings
8.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
379
Price
$501.93
Total Value
$190.23K
Shares Held After
2,531
% of Holdings
13.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
495
Price
$500.96
Total Value
$247.98K
Shares Held After
2,910
% of Holdings
14.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,058
Price
$499.85
Total Value
$528.85K
Shares Held After
3,405
% of Holdings
23.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,371
Price
$498.95
Total Value
$684.07K
Shares Held After
4,463
% of Holdings
23.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,075
Price
$498.01
Total Value
$535.36K
Shares Held After
5,834
% of Holdings
15.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
407
Price
$496.71
Total Value
$202.16K
Shares Held After
6,909
% of Holdings
5.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
555
Price
$495.87
Total Value
$275.21K
Shares Held After
7,316
% of Holdings
7.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
680
Price
$494.75
Total Value
$336.43K
Shares Held After
7,871
% of Holdings
8.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
456
Price
$493.71
Total Value
$225.13K
Shares Held After
8,551
% of Holdings
5.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
340
Price
$492.53
Total Value
$167.46K
Shares Held After
9,007
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
283
Price
$491.68
Total Value
$139.15K
Shares Held After
9,347
% of Holdings
2.9%
LIGAND PHARMACEUTICALS INC (LGND)
Sabba Stephen L — Director
Shares
2,034
Price
$201.50
Total Value
$409.85K
Shares Held After
33,793
% of Holdings
5.7%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
14,233
Price
$16.52
Total Value
$235.13K
Shares Held After
1,155,291
% of Holdings
1.2%
Xencor Inc (XNCR)
Dahiyat Bassil I — Director
Shares
6,758
Price
$11.90
Total Value
$80.39K
Shares Held After
567,792
% of Holdings
1.2%
Xencor Inc (XNCR)
Eckert Celia — SVP, GENERAL COUNSEL
Shares
1,492
Price
$11.90
Total Value
$17.75K
Shares Held After
81,929
% of Holdings
1.8%
Xencor Inc (XNCR)
Desjarlais John R — SR. VICE PRESIDENT & CSO
Shares
2,663
Price
$11.90
Total Value
$31.68K
Shares Held After
270,451
% of Holdings
1.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
359
Price
$321.58
Total Value
$115.45K
Shares Held After
21,860
% of Holdings
1.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
722
Price
$320.51
Total Value
$231.41K
Shares Held After
22,219
% of Holdings
3.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
282
Price
$318.62
Total Value
$89.85K
Shares Held After
22,941
% of Holdings
1.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
289
Price
$316.55
Total Value
$91.48K
Shares Held After
23,223
% of Holdings
1.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
463
Price
$321.50
Total Value
$148.85K
Shares Held After
23,406
% of Holdings
1.9%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
640
Price
$320.48
Total Value
$205.11K
Shares Held After
23,869
% of Holdings
2.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
317
Price
$319.06
Total Value
$101.14K
Shares Held After
24,509
% of Holdings
1.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
355
Price
$316.74
Total Value
$112.44K
Shares Held After
24,826
% of Holdings
1.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
6,519
Price
$69.33
Total Value
$451.98K
Shares Held After
767,780
% of Holdings
0.8%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
13,481
Price
$68.85
Total Value
$928.17K
Shares Held After
774,299
% of Holdings
1.7%
Edesa Biotech, Inc. (EDSA)
Nijhawan Pardeep — Director
Shares
10,000
Price
$3.63
Total Value
$36.30K
Shares Held After
382,702
% of Holdings
2.6%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
200
Price
$41.66
Total Value
$8.33K
Shares Held After
97,994
% of Holdings
0.2%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
2,300
Price
$40.56
Total Value
$93.29K
Shares Held After
98,194
% of Holdings
2.3%
Ultragenyx Pharmaceutical Inc. (RARE)
Parschauer Karah Herdman — EVP and Chief Legal Officer
Shares
8,135
Price
$22.80
Total Value
$185.48K
Shares Held After
76,346
% of Holdings
9.6%
Ultragenyx Pharmaceutical Inc. (RARE)
Crombez Eric — EVP and Chief Medical Officer
Shares
7,029
Price
$22.80
Total Value
$160.26K
Shares Held After
76,301
% of Holdings
8.4%
Liquidia Corp (LQDA)
Schundler Russell — General Counsel
Shares
1,073
Price
$30.58
Total Value
$32.81K
Shares Held After
614,057
% of Holdings
0.2%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
20
Price
$789.28
Total Value
$15.79K
Shares Held After
17,703
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
20
Price
$788.96
Total Value
$15.78K
Shares Held After
17,723
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
2
Price
$787.34
Total Value
$1.57K
Shares Held After
17,743
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
7
Price
$786.61
Total Value
$5.51K
Shares Held After
17,745
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
11
Price
$785.48
Total Value
$8.64K
Shares Held After
17,752
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
9
Price
$784.48
Total Value
$7.06K
Shares Held After
17,763
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
10
Price
$783.62
Total Value
$7.84K
Shares Held After
17,772
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
2
Price
$782.62
Total Value
$1.57K
Shares Held After
17,782
% of Holdings
0.0%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Goff Brian — Director
Shares
5,918
Price
$28.96
Total Value
$171.39K
Shares Held After
164,548
% of Holdings
3.5%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
2
Price
$781.21
Total Value
$1.56K
Shares Held After
17,784
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
3
Price
$780.69
Total Value
$2.34K
Shares Held After
17,786
% of Holdings
0.0%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Goff Brian — Director
Shares
8,267
Price
$28.96
Total Value
$239.41K
Shares Held After
157,466
% of Holdings
5.0%
Showing 801–850 of 1179 transactions (page 17 of 24)